Sodium valproate is an anticonvulsant medication used primarily to treat epilepsy, bipolar disorder, and prevent migraines. It works by calming excessive electrical activity in the brain, and it has been one of the most widely prescribed neurological medications worldwide since the 1970s. You may know it by brand names like Epilim, Depakote, or Depakene, depending on where you live and which specific formulation your doctor prescribes.
How Sodium Valproate Works
The brain relies on a careful balance between signals that excite nerve cells and signals that inhibit them. Seizures, manic episodes, and certain types of migraine occur when that balance tips too far toward excitation. Sodium valproate tips it back in several ways at once, which is part of what makes it effective across different conditions.
Its most important action involves a brain chemical called GABA, which is the nervous system’s main “calm down” signal. Sodium valproate blocks the enzyme that breaks GABA down, so GABA levels rise and neurons become harder to over-excite. At the same time, it acts on sodium and calcium channels in nerve cells, making it harder for runaway electrical signals to spread. It also appears to reduce levels of excitatory amino acids like aspartate, which further dampens overactive signaling. No single one of these mechanisms fully explains the drug’s effects, and researchers still consider the complete picture somewhat unclear.
Conditions It Treats
Sodium valproate is approved for several distinct uses:
- Epilepsy: It treats complex partial seizures (either alone or in combination with other medications) and simple and complex absence seizures. It is also used alongside other drugs for people who experience multiple seizure types. It is one of the broadest-spectrum anti-seizure medications available.
- Bipolar disorder: A related formulation, divalproex sodium (Depakote), is approved to treat manic episodes. It helps stabilize mood during the intense highs of bipolar disorder and is sometimes used for longer-term maintenance.
- Migraine prevention: Depakote is also approved to reduce how often migraines occur. It does not stop a migraine once it has started but can lower the overall frequency when taken daily.
The drug is sometimes prescribed off-label for other conditions involving nerve pain or mood instability, but the three uses above are the ones regulatory agencies have formally approved.
Typical Dosing
Doctors almost always start with a low dose and increase it gradually over days or weeks to reduce the chance of side effects. For epilepsy in adults and children 12 and older, the usual maintenance dose ranges from 600 mg to 2,000 mg per day, taken as a single dose or split into two. Some people need up to 2,500 mg daily. For bipolar disorder, the typical range is 750 mg to 2,000 mg per day.
Your doctor will likely order blood tests periodically to check that the amount of drug in your bloodstream falls within the therapeutic window. The generally accepted target range for total valproic acid in blood is 50 to 125 mcg/mL. Levels above 125 mcg/mL raise the risk of toxic effects, while levels below 50 mcg/mL may mean the dose is too low to be effective. These blood draws are especially common during the first few months of treatment or after any dose change.
Common Side Effects
The most frequently reported side effects tend to be manageable but can be persistent enough to affect daily life. Nausea, vomiting, diarrhea, and loss of appetite are common, particularly when you first start the medication or increase the dose. Taking it with food or using an enteric-coated formulation often helps with stomach upset.
Weight gain is one of the side effects people notice most. It is classified as a common occurrence and can be significant enough that some people and their doctors reconsider the medication over time. Hair thinning or hair loss is also common, though hair typically regrows if the dose is lowered or the drug is stopped. Tremor in the hands or feet is another frequent complaint that can interfere with fine motor tasks like writing or using a phone.
Drowsiness, dizziness, and difficulty concentrating are reported often as well, particularly early in treatment. Many of these side effects improve as your body adjusts, but some, like weight gain, may persist.
Serious Risks to Be Aware Of
Liver Damage
Sodium valproate carries a risk of serious, potentially fatal liver toxicity. Early warning signs include unusual fatigue, weakness, swelling of the face, loss of appetite, and vomiting. In people with epilepsy, a sudden return of seizures after a period of good control can also signal liver problems. The risk is highest during the first six months of treatment, which is why doctors order liver function tests before starting the drug and at regular intervals in that early window. However, blood tests alone do not always catch liver problems early enough, so reporting any new symptoms promptly matters.
Pancreatitis
Inflammation of the pancreas is a rarer but serious risk. Symptoms include severe abdominal pain, nausea, vomiting, and loss of appetite. These symptoms can appear at any point during treatment, not just in the first few months. If you develop sudden, severe stomach pain while taking sodium valproate, that warrants immediate medical attention.
Pregnancy and Sodium Valproate
This is the single most important safety issue surrounding sodium valproate. The drug poses a substantial risk to a developing fetus, and regulatory agencies in the U.S., U.K., and Europe have placed strict restrictions on prescribing it to women of childbearing age.
A large study published in the journal Neurology found that roughly 10.7% of babies exposed to valproate during pregnancy had major birth defects, compared to about 2.9% in the general comparison group. That means the risk was approximately four times higher than average. When compared against the broader population rate of about 1.6%, the relative risk jumped to more than seven times the norm. Common malformations include spina bifida, heart defects, and facial abnormalities.
Beyond structural birth defects, prenatal exposure has been linked to neurodevelopmental problems, including lower IQ scores and an increased risk of autism spectrum disorder, though large-scale prospective studies are still refining those numbers. Because of these risks, sodium valproate is generally not prescribed to women who could become pregnant unless no alternative treatment works and a strict pregnancy prevention program is in place. If you are taking this medication and are considering pregnancy, or if you become pregnant unexpectedly, talking with your prescriber immediately is essential. Stopping the drug abruptly can be dangerous, especially for epilepsy, so any changes need to be managed carefully.
Brand Names and Formulations
Sodium valproate belongs to a family of closely related drugs that all convert to valproic acid in the body. The distinctions between them are mostly about how the medication is formulated and absorbed, not about what it ultimately does. In the U.S., you will encounter valproic acid sold as Depakene, divalproex sodium sold as Depakote (available in standard and extended-release versions), and valproate sodium sold as Depacon for intravenous use. In the U.K. and many other countries, Epilim is the most recognized brand name. Generic versions are widely available everywhere.
Extended-release formulations are taken once daily and may cause fewer gastrointestinal side effects because the drug is released more slowly. Standard formulations are typically split into two doses per day. Your doctor may switch between formulations to find the one your body tolerates best, though the total daily dose may need adjusting when switching because extended-release versions are absorbed differently.